title: [Hyperuricemia, gout, pseudogout and concomitant diseases].
authors: Klinik für Nieren- und Hochdruckerkrankungen, Medizinische, Hochschule, Hannover.
authors: B M W
authors: BM
authors: Schmidt
authors: A D
authors: AD
authors: Wagner
mesh_terms: D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002805:Chondrocalcinosis / Q000175:diagnosis / Q000188:drug therapy*; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy; D000069465:Febuxostat; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D019983:Guideline Adherence; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis / Q000188:drug therapy; D033461:Hyperuricemia / Q000175:diagnosis / Q000188:drug therapy*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006074:Gout Suppressants; D053590:Interleukin 1 Receptor Antagonist Protein; D013844:Thiazoles; D000069465:Febuxostat; C541220:canakinumab; D000493:Allopurinol; D014969:Xanthine Oxidase